Suspension of trading
Valuation Simulations Plus
Stocks
SLP
US8292141053
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
04:00:00 2026-10-05 pm EDT
|
5-day change | 1st Jan Change | ||
| 18.50 USD | 0.00% |
|
0.00% | +1.48% |
Company Valuation: Simulations Plus
Data adjusted to current consolidation scope
| Fiscal Period: August | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,169 | 891.9 | 1,215 | 886.5 | 725.3 | 285.2 |
| Change | - | -23.73% | 36.24% | -27.04% | -18.19% | -60.68% |
| Enterprise Value (EV) 1 | 1,054 | 769.6 | 1,088 | 772.3 | 706 | 253.5 |
| Change | - | -27.01% | 41.42% | -29.04% | -8.58% | -64.1% |
| P/E | 119x | 94.3x | 100x | 90.8x | 74x | -4.4x |
| PBR | 7.61x | 5.38x | 6.83x | 5.22x | 3.98x | 2.29x |
| PEG | - | -15.72x | 3.6x | -5x | - | 0x |
| Capitalization / Revenue | 28.1x | 19.2x | 22.5x | 14.9x | 10.4x | 3.6x |
| EV / Revenue | 25.4x | 16.6x | 20.2x | 13x | 10.1x | 3.2x |
| EV / EBITDA | 74.1x | 57.2x | 63x | 52x | 57.4x | 20.6x |
| EV / EBIT | 81x | 68.4x | 73x | 61.7x | 80.9x | 35.2x |
| EV / FCF | 151x | 62.5x | 209x | 38.3x | 76.5x | 25x |
| FCF Yield | 0.66% | 1.6% | 0.48% | 2.61% | 1.31% | 4.01% |
| Dividend per Share 2 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | - |
| Rate of return | 0.4% | 0.54% | 0.4% | 0.54% | 0.66% | - |
| EPS 2 | 0.5 | 0.47 | 0.6 | 0.49 | 0.49 | -3.22 |
| Distribution rate | 48% | 51.1% | 40% | 49% | 49% | - |
| Net sales 1 | 41.59 | 46.47 | 53.91 | 59.58 | 70.01 | 79.18 |
| EBITDA 1 | 14.23 | 13.44 | 17.28 | 14.86 | 12.3 | 12.3 |
| EBIT 1 | 13.02 | 11.25 | 14.91 | 12.52 | 8.731 | 7.192 |
| Net income 1 | 9.332 | 9.782 | 12.48 | 9.961 | 9.954 | -64.72 |
| Net Debt 1 | -115.1 | -122.3 | -126.8 | -114.3 | -19.25 | -31.74 |
| Reference price 2 | 59.58 | 44.30 | 60.05 | 44.49 | 36.25 | 14.17 |
| Nbr of stocks (in thousands) | 19,627 | 20,133 | 20,236 | 19,927 | 20,008 | 20,127 |
| Announcement Date | 11/16/20 | 10/27/21 | 10/28/22 | 10/27/23 | 10/30/24 | 12/1/25 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 374M | ||
| 35.52x | 6x | 23.03x | 0.27% | 256B | ||
| 36.88x | 7x | 21.91x | 0.62% | 163B | ||
| 51.4x | 12.45x | 26.72x | -.--% | 155B | ||
| 17.1x | 3.39x | 11.04x | -.--% | 65.3B | ||
| 36x | 7.21x | 22.79x | -.--% | 52.35B | ||
| 20.51x | 2.46x | 12.42x | 2.46% | 51.93B | ||
| 47.99x | 11.84x | 26.1x | -.--% | 50.75B | ||
| 34.58x | 6.85x | 23.26x | 0.58% | 50.04B | ||
| 82.02x | 7.79x | 23.64x | -.--% | 46.03B | ||
| Average | 40.22x | 7.22x | 21.21x | 0.44% | 89.08B | |
| Weighted average by Cap. | 39.39x | 7.45x | 22.17x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SLP Stock
- Valuation Simulations Plus
Select your edition
All financial news and data tailored to specific country editions
















